Effect of Paricalcitol on Left Ventricular Mass and Function in CKD—The OPERA Trial - Wang, Angela Yee-Moon; Fang, Fang; Chan, John; Wen, Yue-Yi; Qing, Shang; Chan, Iris Hiu-Shuen; Lo, Gladys; Lai, Kar-Neng; Lo, Wai-Kei; Lam, Christopher Wai-Kei; Yu, Cheuk-Man (Journal of the American Society of Nephrology, 2014)
Keywords: Aged; Alkaline Phosphatase - blood; Biological and medical sciences; Blood Pressure - drug effects; Clinical Research; Double-Blind Method; Echocardiography; Ergocalciferols - adverse effects; Ergocalciferols - therapeutic use; Female; Humans; Hypercalcemia - chemically induced; Hypertrophy, Left Ventricular - drug therapy; Hypertrophy, Left Ventricular - etiology; Hypertrophy, Left Ventricular - pathology; Kidneys; Magnetic Resonance Imaging; Male; Medical sciences; Middle Aged; Nephrology. Urinary tract diseases; Nephropathies. Renovascular diseases. Renal failure; Parathyroid Hormone - blood; Prospective Studies; Renal failure; Renal Insufficiency, Chronic - complications; Renal Insufficiency, Chronic - drug therapy; Renal Insufficiency, Chronic - pathology; Urinary system involvement in other diseases. Miscellaneous; Ventricular Dysfunction, Left - drug therapy; Ventricular Dysfunction, Left - etiology; Ventricular Dysfunction, Left - physiopathology; Kidney disease; Agonist; Nephrology; Urinary system disease; Chronic kidney disease; Urology; Mass; Vitamin D; Analog; Renal failure; Paricalcitol; Clinical trial; Left ventricle performance